Cyteir Therapeutics Receives $2M Grant from National Cancer Institute
cyteir2018-03-07T22:48:24-05:00Cyteir Therapeutics Receives $2M Grant from National Cancer Institute CAMBRIDGE, Mass. – June 29, 2016 – Cyteir Therapeutics, Inc., a leader in the development of novel therapeutics based on the biology of DNA repair, today announced that it has received a $2 million, two-year grant from the National Cancer Institute (NCI), part of the National Institutes [...]